Biodextris

Bioproduction Analytical Services in Laval, Quebec 

Looking for Advanced Analytical Services in Bioproduction?

We cover a wide array of biologic and small molecule products, providing tailored analytical solutions to meet the diverse needs of the pharmaceutical and biotech industries

Comprehensive GMP Analytical Services at Biodextris

Choose Biodextris for your GMP analytical needs as we are experts in developing complete analytical packages, including stability studies, to cover a wide array of biologic and small molecule product.

Method Development

Biodextris supports you in the design of a suite of analytical assays that assess the important and critical quality attributes for your unique product. Our team of talented scientists follow a systematic structured methodology to develop each assay optimized for your product.

Book an Appointment

Method Validation

Validation of a method is a critical step of development work. We, at Biodextris, validate your assays to demonstrate that the appropriate performance criteria are met, and the analytical target profile is achieved. Our quality management system ensures validation policies are aligned with the ICH method validation guidelines ICH Q2(R1).

We assess and verify the following assay parameters as appropriate for your project:

  • Specificity
  • Range
  • Accuracy
  • Precision
  • Repeatability
  • Intermediate Precision
  • Linearity
  • Detection Limit
  • Quantification Limit
  • Robustness

USP methods are performed as defined, or are adapted, customized and validated as appropriate.

Book an Appointment

Method Transfer

Our clients and their situations are all different and as such Biodextris can offer up a wide array of options when it comes to method transfer. On inward bound method transfers we can take in a method and simply transfer and execute, or if requested, we can offer our expertise to further optimize it.


With outward bound transfers we offer full support to help our clients (and their partners) get our new methods up and running with comprehensive documentation and access to our team’s expertise. Quality is our guarantee!

Book an Appointment

QC and Stability Testing

Clinical Drug Substance - Product Analysis

We support you to confidently release your clinical product by executing validated assays which form the backbone of your product monograph or IND CMC section, and establish the quality, efficacy and safety of your product.


Our technologies allow complete analysis of bulk drug substance and liquid or lyophilized drug product, and the validated analytical methods are performed under rigorous quality oversight, following defined standard operating procedures.Your data integrity is assured and your results are handled securely.

Clinical Drug Substance - Product Stability

We help you build a stability plan that captures the essential storage-dependent characteristics of your product to verify quality, efficacy and safety are maintained and providing critical shelf-life determination data. The curated selection of stability-indicating assays are implemented at the defined time-points, and validated storage conditions are employed. Be assured that your stability assays are never considered routine by our diligent scientific team.

Book an Appointment

Available Analytical Technologies

CATEGORY TECHNIQUE/EQUIPMENT OBJECTIVE
Physico-chemical Capillary isoelectric focusing (cIEF) separation of protein variants
Microfluidic electrophoresis automated protein sizing and relative quantitation
HPLC-RP/IEX with PDA/CAD/Fluo: High Performance Liquid Chromatography with Reverse Phase/Ion-Exchange/Size-Exclusion with Photo Diode array or Charge Aerosol or Fluorescence detection Content or purity determination of proteins or small molecules
UPLC-PDA-MS/MS: Ultra Performance Liquid Chromatography with Photo Diode Array or Tandem Mass Spectroscopy detection Multi-analyte determination
LAL Endotoxin: Limulus amebocyte lysate assay Quantification of residual LPS or endotoxin
Colorimetry (optical density, absorbance and transmission) cuvette and multiwell plate. Optical quantification, BCA, Lowry etc.
SDS-PAGE: Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis Size separation and purity determination
Biophysical SEC-MALLS: Size-exclusion Chromatography with Multi-Angle Laser Light Scattering Direct molar mass and size distribution
SEC-FLUO/UV: Fluorescence or ultraviolet-detection Size-exclusion Chromatography Aggregation determination
DLS: Dynamic Light scattering Particle size and size distribution determination
Nephelometry Detection of insoluable particles
Immunological Western Blot Size separation and antigen specificity characterization
ELISA: Enzyme-Linked Immunosorbent Assay Antigenic activity and identification
qPCR Quantification of target or residual DNA
SRID: Single Radial Immunodiffusion Hemagglutinin potency assay
General Osmolality: Aqueous/freeze dried solutions Enumeration of moisture content
pH: Aqueous solutions Levels of acidity or alkalinity determined
Turbidity Measurement of relative clarity of a liquid against guidelines or specifications
Viscosity (Brookfield method) Viscosity, or , flow resistance of liquid in stated conditions
Photostability Simulated prolonged light exposure stability studies
Visual Inspection (EP and USP) Observation according to noted standards
Cell-based assays Potency of target molecules

Your Health And Safety Is Important To Us

Get in Touch With Us

Drop us a Message

Please feel welcome to contact our friendly reception staff with any enquiry. We will answer to you shortly!

Analytical Service - Contact us

Recent Articles

Tips, News and Updates

By Philippe Beland June 11, 2025
Biodextris Appoints Dr. Behzad Mahdavi as Executive Chairman & Chief Commercial Officer Who: Dr. Behzad Mahdavi, Ph.D., MBA, NACD.DC — a biopharma industry veteran with over 25 years of senior leadership experience in CDMO and CRO sectors, including roles at Lonza and Catalent. What: He has been appointed Executive Chairman and will additionally serve as Chief Commercial Officer at Biodextris. Why: Dr. Mahdavi will spearhead the company’s global commercial expansion, leveraging his expertise in commercial innovation and international market development About Biodextris: Headquartered in Laval (Montréal), Québec, Biodextris is a rising Contract Development & Manufacturing Organization (CDMO) specializing in biologics and vaccine development, rooted in the legacy of GSK’s biologics and supported by ArchiMed private equity. For full details, you can read the original PR Newswire article here: https://www.prnewswire.com/news-releases/biodextris-appoints-dr-behzad-mahdavi-as-executive-chairman-to-lead-global-commercial-expansion-302472664.html
December 17, 2024
Learn about the strategic partnership between Aramis Biotechnologies and Biodextris to advance vaccine and biologics development.
December 17, 2024
Clean Biologics acquires Biodextris—bringing together expertise in biologics manufacturing and accelerating growth in CDMO services.

FAQs

Got a question? We’re here to help.

  • Where is your main office?

    The office is located in Laval